Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Will COVID-19 Derail New Drugs?

TheMotleyFool

0 0

Business disruptions due to COVID-19 represent a new risk for investors across all sectors. Expect to see language addressing this added to the risk factors section of 10-K annual reports filed with the Securities and Exchange Commission (SEC).

For biotech and pharma companies, COVID-19 will impede clinical trials and slow down regulatory actions. Here we will explore some of the emerging issues based on what can only be described as a very fluid situation globally.

Image Source: Getty Images

Source Fool.com

Like: 0

GILD

Share